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Impact of Early-Life Bisphenol A Exposure on Behavior
and Executive Function in Children
WHAT’S KNOWN ON THIS SUBJECT: Virtually all persons in
industrialized countries are exposed to bisphenol A (BPA), and
early-life BPA exposure might be associated with behavior
problems. Few human studies have been conducted, and the
impact of gestational versus childhood BPA exposures is unclear.
WHAT THIS STUDY ADDS: BPA exposure during pregnancy, but
not childhood, was associated with worse behavior at 3 years of
age, especially among girls. Domains related to behavioral and
emotional regulation were most affected by gestational BPA
exposure.
abstract
OBJECTIVES: To estimate the impact of gestational and childhood bis-
phenol A (BPA) exposures on behavior and executive function at 3 years
of age and to determine whether child gender modified those
associations.
METHODS: We used a prospective birth cohort of 244 mothers and
their 3-year-old children from the greater Cincinnati, Ohio, area. We
characterized gestational and childhood BPA exposures by using the
mean BPA concentrations in maternal (16 and 26 weeks of gestation
and birth) and child (1, 2, and 3 years of age) urine samples, respec-
tively. Behavior and executive function were measured by using the
Behavior Assessment System for Children 2 (BASC-2) and the Behavior
Rating Inventory of Executive Function-Preschool (BRIEF-P).
RESULTS: BPA was detected in 97% of the gestational (median: 2.0
g/L) and childhood (median: 4.1 g/L) urine samples. With adjust-
ment for confounders, each 10-fold increase in gestational BPA concen-
trations was associated withmore anxious and depressed behavior on
the BASC-2 and poorer emotional control and inhibition on the BRIEF-P.
The magnitude of the gestational BPA associations differed according
to child gender; BASC-2 and BRIEF-P scores increased 9 to 12 points
among girls, but changes were null or negative among boys. Associa-
tions between childhood BPA exposure and neurobehavior were
largely null and not modified by child gender.
CONCLUSIONS: In this study, gestational BPA exposure affected behav-
ioral and emotional regulation domains at 3 years of age, especially
among girls. Clinicians may advise concerned patients to reduce their
exposure to certain consumer products, but the benefits of such re-
ductions are unclear. Pediatrics 2011;128:873–882
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Bisphenol A (BPA) is used in a variety
of consumer products, including
dental sealants, food/beverage con-
tainers and linings, medical equip-
ment, and thermal receipts.1 The use
of BPA-containing products in daily
life makes exposure ubiquitous in
industrialized and industrializing
countries.2–5 The predominant source
of BPA exposure for most people is
diet, although exposure also might oc-
cur through inhalation or dermal ab-
sorption, which results in substantial
exposure among persons involved in
the manufacture or handling of BPA-
containing products.6–10
BPA might disrupt the endocrine sys-
tem.11 Experimental studies with ani-
mals indicated that gestational BPA
exposure disrupts normal neurode-
velopment, affecting sexually dimor-
phic behaviors such as aggression,
anxiety, exploration, and spatial mem-
ory.12–14 Sexually dimorphic clinical
disorders such as attention-deficit/hy-
peractivity disorder, autism, and de-
pression might be clinical correlates
of these animal behaviors and might
be related to early-life disruption of the
endocrine system.15,16 These observa-
tions suggest that sexually dimorphic
behavioral traits may serve as sensi-
tive end points in epidemiological
studies.
We reported previously that gesta-
tional BPA exposure was associated
with increased hyperactivity and ag-
gression scores for 2-year-old girls in
a prospective birth cohort from Cincin-
nati, Ohio.2 However, important ques-
tions remain about these findings. The
children were young, and the observed
associations might not persist with
continued development. Furthermore,
our previous study was unable to ex-
amine the relationship between BPA
exposure and executive function,
which is a set of processes involved in
inhibiting behavior, modulating emo-
tions, and shifting between activities.
Deficits in executive function are a fea-
ture of disorders such as attention-
deficit/hyperactivity disorder.17 Finally,
we did not examine the impact of in-
fant/childhood BPA exposures on
neurobehavior.
Additional research examining the
neurotoxicity of BPA is needed, given
the pervasiveness of exposure and the
potential for even small effects to
have substantial public health conse-
quences.1,18 The purpose of this study
was to determine whether previously
observed associations remained at 3
years of age, whether executive func-
tions were affected by BPA exposure,
and whether gestational or childhood




Data for this study were collected from
mothers and their children who were
participating in the Health Outcomes
and Measures of the Environment
Study, a prospective birth cohort in the
Cincinnati, Ohio, metropolitan area de-
signed for the study of low-level envi-
ronmental toxicant exposures.19 Eligi-
bility criteria and enrollment of this
cohort were described previously.2
Urinary BPA Concentrations
Three maternal spot urine samples
were collected between March 2003
and January 2006, twice during preg-
nancy, at 16 and 26 weeks of ges-
tation, and within 24 hours after birth.
Children’s spot urine samples were
collected at 1, 2, and 3 years of age,
during clinic or home visits, between
2004 and 2009. Preference was given
to samples collected during home vis-
its because collection conditions were
more standardized. Urine was col-
lected directly into polypropylene
specimen cups or, for non–toilet-
trained infants, first into Kendall ab-
dominal pads placed inside the diaper.
Urine was stored at or below 20°C
until analysis. Diaper inserts contami-
nated with stool were not analyzed.
The concentrations of total (free plus
conjugated) species of BPA were mea-
sured at the Centers for Disease Con-
trol and Prevention (CDC), by using
modified analytical chemistry meth-
ods described previously.20 The limit of
detection (LOD) was 0.4 g/L; concen-
trations below the LOD were given a
value of LOD/2.21
We characterized gestational and
childhood BPA exposures by using
the mean of 2 urine samples from
the respective periods (ie, gestation
or childhood), because individual
urinary BPA concentrations vary
and a single measure may misclas-
sify exposure.22 We corrected for
urine dilution by using urinary creat-
inine concentrations and calculated
creatinine-standardized BPA concen-
trations (versus nonstandardized)
by dividing individual urinary BPA
concentrations by creatinine con-
centrations before calculating the
mean.
Childhood Behavior and Executive
Function
Children’s behavior was assessed at 3
years of age by using the Behavior
Assessment System for Children 2
(BASC-2) Parent Rating Scale for pre-
schoolers. The BASC-2 is a valid, reli-
able, 134-item, parent-report assess-
ment of a child’s problem behaviors in
community and home settings.23 We fo-
cused on clinical subscales because
they might be more relevant to human
behaviors and more comparable to
behavioral end points used in animal
studies.24 The analyzed subscales in-
cluded aggression, attention, hyper-
activity, depression, anxiety, and
somatization.
Children’s executive functions at 3
years of age were assessed by using
the Behavior Rating Inventory of Exec-
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utive Function-Preschool (BRIEF-P), a
reliable, valid, 63-question, parent-
report inventory.25 Our analyses fo-
cused on 5 clinical scales from the
BRIEF-P; emotional control scores as-
sess the ability to modulate emotions,
inhibit scores reflect the capacity to
control behavioral responses, plan/or-
ganize scores assess the ability to an-
ticipate and to plan for future events,
to set goals, and to grasp main ideas,
shift scores measure the capacity to
transition to and from events, and
working memory scores measure the
ability to hold information in mind for
completing a task.
Parents were unaware of their own or
their children’s urinary BPA concen-
trations when they completed the 2 be-
havioral measures. Scores on the
BASC-2 and BRIEF-P were normalized to
a mean of 50 (SD: 10) by the test pub-
lishers. For both instruments, higher
scores indicate more impairment.
Subscales of the BASC-2 and BRIEF-P
share a moderate degree of correla-
tion (Pearson R  0.5–0.7), and each
test has been used to validate the
other.23,26 We also used 2 summary
scores from the BASC-2 (Behavioral
Symptom Index) and BRIEF-P (Global
Executive Composite) to describe the
study sample and how behavior var-
ied according to child and family
characteristics.
Covariates
We included the following potential con-
founding variables in our exposure-
outcome statistical models.22,27 Demo-
graphic variables (mother’s race,
education, marital status, and house-
hold income) were measured by
trained interviewers during preg-
nancy. Perinatal variables included
maternal depressive symptoms mea-
sured at 20 weeks of gestation by us-
ing the Beck Depression Inventory II.28
The caregiving environment was mea-
sured through administration of the
Home Observation for Measurement of
the Environment during the 1-year
home visit.29
We controlled for gestational exposure
to low molecular weight phthalates
(compounds used in personal care
products and other consumer prod-
ucts) and tobacco smoke by using me-
tabolite concentrations frommaternal
urine and serum measurements, re-
spectively. We calculated the mean
concentrations of cotinine (a metabo-
lite of nicotine) or low molecular
weight phthalates from 2 samples
collected during pregnancy or at birth.
We used the summed molar concen-
trations of 3 low molecular weight
phthalate metabolites, on the basis of
their previous associations with child-
hood behavior and executive func-
tion.30 Metabolite concentrations were
quantified at the CDC by using previ-
ously described methods.31,32
Statistical Analyses
We began by describing Global Execu-
tive Composite and Behavioral Symp-
tom Index scores according to so-
ciodemographic factors. We also
examined univariate characteristics of
urinary BPA concentrations. We calcu-
lated Pearson correlation coefficients
between pairs of log10-transformed
urinary BPA concentrations, to gauge
their variability.
We fit 3-knot, restricted, cubic splines
to examine the dose-response rela-
tionship and to examine model linear-
ity assumptions for urinary BPA
concentrations and neurobehavior.33
Restricted cubic polynomial splines al-
low the shape of the relationship be-
tween the exposure and outcome to be
flexible and not inherently linear. We
used multivariate linear regression to
estimate the unadjusted and adjusted
changes in BASC-2 and BRIEF-P scores
with each 10-fold increase in urinary
BPA concentrations during gestation
or childhood. We also included the
child’s gender and a product interac-
tion term between BPA variables and
child gender because our previous
findings suggested that child gender
modified the association between ges-
tational BPA concentrations and neu-
robehavior.2 We examined the P values
for this interaction term and consid-
ered values of.10 to be indicative of
modification, because our statistical
power was limited by sample size.34
Secondary Analyses
First, we examinedwhether themutual
adjustment for gestational and child-
hood urinary BPA concentrations
changed the pattern of our results.
Second, we examined whether addi-
tional adjustment for maternal IQ
(Wechsler Abbreviated Scales of Intel-
ligence), parity, or duration of breast-
feeding (postnatal models only)
changed the pattern of observed re-
sults.35 Third, we examined whether
missing data biased our results by an-
alyzing data for the subsets of women
and children who had all 3 urine sam-
ples during gestation and childhood,
respectively. Finally, we determined
whether the exclusion of dilute or con-
centrated urine samples changed our
results.3 Dilute urine was defined as
that with creatinine concentrations of
20mg/dL formothers and2mg/dL
for children. Concentrated urine was
defined as that with creatinine concen-
trations of 200 mg/dL for mothers,
128 mg/dL for 1- and 2-year-old chil-
dren, and 150 mg/dL for 3-year old
children.36
Ethical Considerations
The institutional review boards of Cin-
cinnati Children’s Hospital Medical
Center, the cooperating delivery hospi-
tals, and the CDC approved this study.
All mothers provided written informed
consent for themselves and their chil-
dren before enrollment in the study.
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RESULTS
Descriptive Statistics
Of the 468 enrolled women, 67 dropped
out before delivery, 9 delivered twins,
and 3 experienced stillbirths. We also
excluded 1 woman with a urinary BPA
concentration of 1250 g/L.37 Among
the remaining 388 mother-child pairs,
262 (67%) completed follow-up assess-
ments at 3 years of age, and 245 of
those mother-child pairs had gesta-
tional or childhood BPA exposure mea-
surements and complete covariate
data. Among those women, 239 com-
pleted the BASC-2 and 237 completed
the BRIEF-P.
Dyads with complete follow-up data
were more likely to be white, married,
25 to 34 years of age, more educated,
and wealthier, compared with dyads
with incomplete data (results not
shown). Gestational urinary BPA con-
centrations were lower among
women who completed the follow-up
assessments, compared with those
who did not (geometric mean: 2.0 vs
2.5 g/L). However, creatinine-
standardized concentrations were
similar for women with complete
(geometric mean: 2.4 g/g) and in-
complete (geometric mean: 2.5
g/g) follow-up data. Children from
families with lower maternal educa-
tion or household income had higher
BASC-2 and BRIEF-P scores at 3 years
of age (Table 1).
Maternal BPA concentrations were rel-
atively stable between the first sample
and birth (Fig 1 and Table 2). Children’s
urinary BPA concentrations decreased
from 1 to 3 years of age, and this
decrease became more apparent af-
ter creatinine standardization. Chil-
dren’s urinary BPA concentrations
were higher and more variable than
maternal concentrations. We ob-
served weak correlations between
pairs of time-specific maternal-
maternal, child-child, and maternal-
child urinary BPA concentrations
(Pearson R  0.25), which became
weaker after creatinine standardiza-
tion (Pearson R  0.18).
The mean creatinine-standardized
gestational and childhood BPA concen-
trations exhibited a weak correlation
(Pearson R 0.11). Mean BPA concen-
trations from gestation or childhood
were similar in magnitude to individ-
ual measurements but were less
variable.
Urinary BPA Concentrations and
Behavior/Executive Function
The 3-knot, restricted, cubic, polyno-
mial splines revealed approximately
linear relationships between log10-
transformed urinary BPA concentra-
tions and BASC-2/BRIEF-P scores (Fig
2; childhood data not shown). There-
fore, we chose to characterize BPA
concentrations as continuous log10-
transformed variables.








All participants 240 51 9 53 12
Mother’s race
Non-Hispanic white 173 50 8 51 12
Non-Hispanic black 52 54 12 57 12
Other 15 49 8 53 10
Mother’s education
Graduate/professional school 53 49 6 50 11
Bachelor’s degree 89 49 8 51 11
Some college 57 53 10 54 14
High school 24 52 11 57 10
Less than high school 17 55 13 59 10
Mother’s marital status
Married or living with partner 176 50 7 51 11
Unmarried or living alone 64 54 11 57 13
Annual household income
$80 000 or more 75 49 7 50 10
$40 000 to less than $80 000 93 50 8 51 11
$20 000 to less than $40 000 31 51 8 54 14
Less than $20 000 41 56 13 59 12
Maternal depression during pregnancy
Minimal 190 49 8 50 11
Mild 35 56 11 60 12
Moderate or severe 15 62 8 63 13
Child’s gender
Female 128 51 9 52 13
Male 112 51 8 53 11
Home Observation for Measurement of the
Environment score
35 29 54 10 57 12
35–39 38 54 11 57 12
40 173 50 8 51 11
Gestational tobacco smoke exposure
None 103 50 8 52 11
Secondhand smoke 117 51 10 53 13
Active 20 53 8 55 11
Gestational urinary low molecular weight
phthalate concentrations
First quartile (0–0.6 mol/g creatinine) 59 50 8 51 12
Second quartile (0.6–1.2 mol/g creatinine) 60 51 9 53 10
Third quartile (1.2–2.5 mol/g creatinine) 60 51 9 52 12
Fourth quartile (2.5 mol/g creatinine) 61 51 9 54 13
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With adjustment for confounders, ges-
tational BPA concentrations were pos-
itively associated with BASC-2 anxiety,
hyperactivity, and depression scale
scores (Table 3). The magnitude of
these associations was greater among
girls, compared with boys (P  .10).
Anxiety and depression associations
for girls were almost twice as large as
associations for the whole sample,
whereas associations for boys were
close to the null. Notably, gestational
BPA concentrations were associated
with increases in BASC-2 hyperactivity
scores among girls (  9.1 [95% con-
fidence interval [CI]: 3.1–15]) but de-
creases among boys (  6.3 [95%
CI:12 to0.6]). In general, associa-
tions between childhood urinary BPA
concentrations and BASC-2 scores
were positive in direction, and 95% CIs
straddled the null value. We did not ob-
serve evidence that childhood BPA con-
centrations were modified by child
gender.
Gestational BPA concentrations were
positively associated with emotional
control and inhibition scores on the
BRIEF-P with adjustment for confound-
ers (Table 4). The magnitudes of asso-
ciations were similar to those ob-
served for the BASC-2. Associations
between gestational BPA concentra-
tions and emotional control and inhibi-
tion scale scores were larger among
girls, comparedwith boys (interaction
P .10). Associations between child-
hood urinary BPA concentrations
and BRIEF-P scores were null, and
child gender did not modify these
associations.
Adjustment for confounders shifted
most point estimates for associations
between gestational BPA exposure and
BASC-2/BRIEF-P scores up, and in some
cases through the null. Conversely, ad-
justment for confounders shifted most
estimated associations between child-
hood BPA exposure and neurobehav-
ioral scores down, and sometimes
through the null. BPA estimates from
unadjusted and adjusted models had
similar precision, as evidenced by the
95% CI width.
Secondary Analyses
The inclusion of both gestational and
childhood urinary BPA concentrations
in the samemodel did not alter the pat-
tern of observed results, and neither
did adjustment for maternal IQ, parity,
or duration of breastfeeding (results
FIGURE 1
Box plots of nonstandardized and creatinine-standardized urinary BPA concentrations. Creatinine-
standardized urinary BPA concentrations were calculated by dividing urinary BPA concentrations by
urinary creatinine concentrations, to control for urine dilution, whereas nonstandardized concentra-
tions were not. Whiskers represent the minimum and 1.5 times the interquartile range. The tops and
bottoms of the boxes represent the 75th and 25th percentiles, respectively. The lines in the boxes
represent the medians, and the diamonds represent the means. Circles represent extreme observa-
tions (1.5 times the interquartile range).
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not shown). We observed a similar pat-
tern of results when we limited our
analyses to women (n 215) and chil-
dren (n 154)with all 3 urine samples
during gestation and childhood, re-
spectively. The exclusion of women
(n 32) or children (n 13) with di-
lute or concentrated urine did not
change the pattern of results.
DISCUSSION
Gestational urinary BPA concentra-
tions were associated with some neu-
robehavioral measures at 3 years of
age in this cohort. In particular, gesta-
tional BPA exposure was associated
with higher scores for measures of
anxiety, hyperactivity, emotional con-
trol, and behavioral inhibition. Similar
to our previous findings, the effects of
gestational BPA exposure on these be-
havioral domains were larger among
girls than boys.2 The different re-
sponses to gestational BPA exposure
were especially pronounced for hyper-
activity; girls exhibited increases in hy-
peractivity, and boys exhibited de-
creases in hyperactivity. In contrast,
childhood urinary BPA concentrations
were less important predictors of be-
havior or executive functions in this
study.
The findings presented are consistent
with numerous studies demonstrating
altered neurobehavior among BPA-
exposed animals.14,38 Gestational BPA
exposures might affect endocrine or
other neurotransmitter pathways and
disrupt sexual differentiation of the
brain, to alter behavior in a gender-
dependent manner.39,40 However, the
exposures and behavioral end points
used in some animal studies might not
be relevant or comparable to human
cases.41 A recent epidemiological
study suggests that gestational BPA ex-
posure may be associated with im-
paired social behaviors in children.42
However, the authors did not find that
their associations were modified by
child gender.
The association of anxious, hyperac-
tive, and depressive behaviors with
gestational BPA exposure seems para-
doxical at first; however, there is
substantial comorbidity between at-
tention-deficit/hyperactivity disorder,
depression, and anxiety disorders.43
The pattern of observed associations
suggests that gestational BPA expo-
sure may affect neurobehavioral do-
mains associated with behavioral reg-
ulation. Additional research using
neuropsychologically based measures
of these domains would enhance our
understanding of BPA-neurobehavior
relationships.
Our results suggested that girls in this
cohort were more sensitive to gesta-
tional BPA exposures than were boys.
This pattern should be interpreted
cautiously, given the imprecision of the
observed associations among girls












BPA level, g/L of urine
Gestational mean 244 97 LOD 0.5 1.1 2.0 3.3 7.6 37
16 wk 244 89 LOD LOD 0.8 1.8 3.2 9.7 72
26 wk 240 90 LOD LOD 0.8 1.7 3.3 9.4 42
Birth 223 86 LOD LOD 0.7 1.2 2.3 6.8 49
Childhood mean 229 100 0.6 1.2 2.4 4.1 7.0 18 206
1 y 213 97 LOD 0.5 1.8 3.9 7.6 22 325
2 y 195 99 LOD 0.7 1.5 2.9 6.1 24 616
3 y 222 96 LOD 0.5 1.4 2.9 5.2 15 67
Creatinine-standardized BPA level, g/g creatininea
Gestational mean 244 97 0.5 1.1 1.6 2.2 3.5 8.0 20
16 wk 243 89 LOD 0.6 1.1 1.7 3.0 10 38
26 wk 240 89 0.4 0.8 1.4 2.1 3.4 7.9 58
Birth 223 86 LOD 0.6 1.2 1.8 2.8 9.4 27
Childhood mean 229 100 2.3 4.6 7.6 14 21 62 431
1 y 212 97 1.5 4.7 9.9 18 34 91 812
2 y 195 99 1.1 3.0 5.7 9.6 19 63 1273
3 y 222 96 0.9 1.5 3.0 5.3 10 24 95
Creatinine level, mg/dL urine
16 wk 243 100 7.7 20 53 104 160 284 487
26 wk 240 100 9.2 14 42 79 139 264 428
Birth 223 100 9.3 18 37 72 109 190 285
1 y 212 100 3.83 5.8 12 19 34 75 144
2 y 195 100 5.51 6.9 19 35 60 83 201
3 y 222 100 6.9 12 34 54 73 119 269
a Creatinine-standardized urinary BPA concentrations were calculated by dividing urinary BPA concentrations by urinary creatinine concentrations, to control for urine dilution, whereas
nonstandardized concentrations were not.
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and the low statistical power for inter-
actions between gender and BPA expo-
sures. This finding is intriguing, how-
ever, given the endocrine-disrupting
nature of BPA. Future studies should
examine other sexually dimorphic be-
haviors and should address whether
boys and girls have different levels of
susceptibility to BPA at different peri-
ods of development.
The results from analyses using the
BRIEF-P corroborated our findingswith
the BASC-2 and suggest that associa-
tions between gestational BPA expo-
sure and behavior might be related to
poor behavioral regulation. Alterna-
tively, this result might reflect the
shared correlation between these 2
measures, rather than deficits in
performance-based measures of exec-
utive function.25,44 The BRIEF-P may
merely serve as an additional measure
of problem behaviors.
The generalizability of our findings
might vary according to predictors of
neurobehavior and levels of BPA expo-
sure in selected target populations.
Consistent with findings in the United
States, children from lower socioeco-
nomic backgrounds had scores indic-
ative of more behavioral and executive
function impairment. Our observed
urinary BPA concentrations were
similar to those measured in other
studies with pregnant women.3,45,46
Children’s urinary BPA concentra-
tions at 1, 2, and 3 years of age were
higher than concentrations reported
for adults but were slightly lower
than concentrations observed among 6-
to 11-year-old children in previous
studies.47,48 Higher BPA concentra-
tions in children could be attribut-
able to pharmacokinetic factors or
increased food consumption per unit
of body mass.24
Accurate assessment of BPA expo-
sure during the correct period of
susceptibility is difficult. One of the
primary strengths of this study is
that we collected 6 spot urine sam-
ples frommothers and their children
and averaged 2 urinary BPA con-
centrations during gestation or
childhood, to reduce exposure vari-
ability. BPA concentrations in multi-
ple spot urine samples still may ex-
FIGURE 2
Scatterplot and adjusted smoothed regression of gestational urinary BPA concentrations and BASC-2/BRIEF-P subscale scores at 3 years of age: A, girls; B,
boys. Models were adjusted for race (white, black, or other), household income (continuous, in thousands of dollars), education (graduate/professional
school, bachelor’s degree, some college, high school, or less than high school), marital status (married or unmarried), depressive symptoms during
pregnancy (continuous), Home Observation for Measurement of the Environment scores (continuous), log10-transformedmean gestational serum cotinine
concentrations, and log10-transformed mean gestational low molecular weight urinary phthalate concentrations. The relationship was smoothed by using
a restricted, cubic, polynomial spline with knots at the 10th, 50th, and 90th percentiles of the gestational urinary BPA concentrations. Black lines represent
mean regression lines, gray bands are 95% CIs, and dots are raw data.
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hibit substantial within-person
variability but may classify BPA expo-
sure accurately over time scales of
days to weeks.22,47,49,50 With the as-
sumption of nondifferential expo-
sure misclassification, this error
would result in null-biased esti-
mates.51 Integrated exposure mea-
sures such as mean BPA concentra-
tions might reduce misclassification
rates, but they would decrease the
ability to identify short time-
sensitive windows of development.
Future studies should consider the
importance of collecting multiple or
integrated urinary concentration
measurements, to improve exposure
classification during critical win-
dows of neurodevelopment.
We adjusted for a variety of confound-
ers, including factors that are difficult
to measure, such as the caregiving en-
vironment and biomarkers of other en-
vironmental toxicants. Adjustment did
not greatly affect the magnitude of
most estimates, which suggests that
confounding by these factors was not
an important source of bias. However,
additional, unidentified, confounding
factors, including other hormonally ac-
tive chemicals that vary with BPA or
heritable personality traits that influ-
ence BPA exposure and childhood be-
havior, might explain some of the ob-
served associations.
TABLE 3 Unadjusted and Adjusted Changes in BASC-2 Scores at 3 Years of Age With 10-Fold Increases in Creatinine-Standardized Gestational and
Childhood Urinary BPA Concentrations
Change in BASC-2 Score, Estimate (95% CI)
All, Unadjusted All, Adjusted Girls, Adjusteda Boys, Adjusteda
Mean gestational BPA level (n 239)
Aggression scale 1.6 (3.4 to 6.6) 2.1 (2.7 to 6.9) 5.0 (2.1 to 12) 0.2 (6.8 to 6.4)
Hyperactivity scale 0.6 (5.0 to 3.8) 0.5 (3.8 to 4.8) 9.1 (3.1 to 15) 6.3 (12 to0.6)b
Anxiety scale 6.8 (1.6 to 12) 7.0 (1.7 to 12) 12 (4.7 to 20) 1.3 (5.8 to 8.4)b
Depression scale 2.7 (2.3 to 7.7) 4.9 (0.0 to 9.9) 11 (3.6 to 18) 0.5 (7.2 to 6.2)b
Somatization scale 0.4 (3.7 to 4.6) 0.3 (3.9 to 4.5) 5.0 (1.1 to 11) 4.0 (9.6 to 1.7)b
Attention scale 2.2 (6.0 to 1.6) 1.7 (5.5 to 2.1) 0.5 (6.0 to 5.1) 2.2 (7.4 to 3.0)
Mean childhood BPA level (n 225)
Aggression scale 2.7 (1.3 to 6.6) 1.6 (2.4 to 5.7) 0.7 (4.8 to 6.2) 3.1 (2.8 to 9.1)
Hyperactivity scale 0.3 (3.0 to 3.7) 1.0 (4.4 to 2.4) 1.2 (5.8 to 3.3) 0.5 (4.4 to 5.4)
Anxiety scale 2.7 (1.6 to 6.9) 2.9 (1.5 to 7.4) 1.3 (4.7 to 7.4) 3.3 (3.1 to 9.8)
Depression scale 4.3 (0.4 to 8.2) 3.0 (1.1 to 7.1) 2.8 (2.8 to 8.4) 2.9 (3.1 to 8.9)
Somatization scale 3.3 (0.0 to 6.6) 1.6 (1.8 to 5.1) 2.0 (2.7 to 6.8) 1.1 (4.0 to 6.2)
Attention scale 1.5 (1.5 to 4.4) 1.1 (2.0 to 4.3) 1.1 (3.2 to 5.4) 2.3 (2.3 to 6.9)
Models were adjusted for race (white, black, or other), household income (continuous, in thousands of dollars), education (graduate/professional school, bachelor’s degree, some college,
high school, or less than high school), marital status (married or unmarried), depressive symptoms during pregnancy (continuous), Home Observation for Measurement of the Environment
scores (continuous), log10-transformed mean gestational serum cotinine concentrations, and log10-transformed mean gestational low-molecular weight urinary phthalate concentrations.
a Model includes child gender and a BPA level–child gender interaction term.
b For gender–BPA level interaction, P .10.
TABLE 4 Unadjusted and Adjusted Changes in BRIEF-P Scores at 3 Years of Age With 10-Fold Increases in Creatinine-Standardized Gestational and
Childhood Urinary BPA Concentrations
Emotional Control Scale Change in BRIEF-P Score, Estimate (95% CI)
All, Unadjusted All, Adjusted Girls, Adjusteda Boys, Adjusteda
Mean gestational BPA level (n 237)
Emotional control scale 2.9 (1.7 to 7.4) 4.9 (0.5 to 9.3) 9.1 (2.8 to 15) 1.1 (5.1 to 7.2)b
Inhibit scale 2.3 (3.2 to 7.8) 4.1 (1.3 to 9.5) 9.3 (1.8 to 17) 0.4 (7.0 to 7.8)b
Plan/organize scale 0.2 (5.4 to 5.8) 1.1 (4.4 to 6.7) 5.4 (2.5 to 13) 2.2 (10 to 5.5)
Shift scale 1.4 (3.6 to 6.4) 3.1 (2.0 to 8.2) 5.5 (1.7 to 13) 1.4 (5.7 to 8.5)
Working memory scale 0.6 (6.6 to 5.5) 0.6 (5.4 to 6.5) 4.2 (4.3 to 12) 2.4 (11 to 5.9)
Mean childhood BPA level (n 223)
Emotional control scale 3.9 (0.3 to 7.5) 2.5 (1.2 to 6.2) 1.6 (3.4 to 6.7) 4.1 (1.3 to 9.5)
Inhibit scale 1.8 (2.5 to 6.0) 0.7 (5.1 to 3.8) 1.2 (7.1 to 4.7) 2.2 (4.2 to 8.5)
Plan/organize scale 3.7 (0.7 to 8.0) 1.7 (2.9 to 6.3) 1.4 (4.8 to 7.7) 3.3 (3.3 to 10)
Shift scale 1.7 (2.2 to 5.6) 0.0 (4.2 to 4.2) 0.2 (5.5 to 5.9) 1.0 (5.1 to 7.1)
Working memory scale 3.3 (1.4 to 8.0) 1.7 (3.3 to 6.6) 1.2 (5.4 to 7.9) 3.5 (3.7 to 11)
Models were adjusted for race (white, black, or other), household income (continuous, in thousands of dollars), education (graduate/professional school, bachelor’s degree, some college,
high school, or less than high school), marital status (married or unmarried), depressive symptoms during pregnancy (continuous), Home Observation for Measurement of the Environment
scores (continuous), log10-transformed mean gestational serum cotinine concentrations, and log10-transformed mean gestational low-molecular weight urinary phthalate concentrations.
a Model includes child gender and a BPA-child gender interaction term.
b For gender–BPA level interaction, P .10.
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Our sample size was modest, which
reduced our statistical power to test
for gender modification and led to
wide CIs. In addition, we examined
many exposure-outcome associations,
which increased the likelihood that
our results might include the null
value through chance alone. Instead
of applying mathematical corrections
for multiple comparisons, such as
the Dunn-Bonferroni correction, we
avoided strict application and inter-
pretation of statistical significance
thresholds (such as the 95% CI exclud-
ing the null value).52 Instead, we fo-
cused on the patterns, magnitudes,
and consistency of our results and
compared those factors with findings
from our previous studies and experi-
mental studies with animals.38,42
The clinical relevance of these findings
is unclear at this point. Despite this un-
certainty, clinicians can advise con-
cerned patients to reduce their expo-
sure, as well as cautioning that it is
difficult to avoid all sources of expo-
sure and the health consequences of
BPA exposure are not fully understood.
BPA exposure can be reduced by avoid-
ing canned and packaged foods, re-
ceipts, and polycarbonate bottles with
the recycling symbol 7.22,38,53,54
CONCLUSIONS
The results of this study suggest that
gestational BPA exposure might be as-
sociated with anxious, depressive, and
hyperactive behaviors related to im-
paired behavioral regulation at 3 years
of age. This pattern was more pro-
nounced for girls, which suggests that
they might be more vulnerable to ges-
tational BPA exposure than boys. In
contrast, childhood BPA exposure did
not exhibit associations with behavior
and executive function at 3 years of
age. There is considerable debate re-
garding the toxicity of low-level BPA ex-
posure, and the findings presented
here warrant additional research.
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